High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention After Coronary Stent Revascularization: A Landmark Analysis of the ARCTIC Study

Study Questions:

What is the clinical impact of individualizing antiplatelet therapy in patients undergoing primary percutaneous coronary intervention (PCI)?